Cargando…
Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site
Beta-cell replacement therapy is an effective means to restore glucose homeostasis in select humans with autoimmune diabetes. The scarcity of “healthy” human donor pancreata restricts the broader application of this effective curative therapy. “β-Like” cells derived from human embryonic stem cells (...
Autores principales: | Pepper, Andrew R., Pawlick, Rena, Bruni, Antonio, Wink, John, Rafiei, Yasmin, O’Gorman, Doug, Yan-Do, Richard, Gala-Lopez, Boris, Kin, Tatsuya, MacDonald, Patrick E., Shapiro, A.M. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470173/ https://www.ncbi.nlm.nih.gov/pubmed/28591651 http://dx.doi.org/10.1016/j.stemcr.2017.05.004 |
Ejemplares similares
-
Clinical islet isolation outcomes with a highly purified neutral protease for pancreas dissociation
por: O'Gorman, Doug, et al.
Publicado: (2013) -
Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation
por: Abualhassan, Nasser, et al.
Publicado: (2016) -
Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device
por: Pepper, Andrew R., et al.
Publicado: (2015) -
Prevascularization-free Primary Subcutaneous Transplantation of Xenogeneic Islets Coencapsulated With Hepatocyte Growth Factor
por: Yang, Sin-Yu, et al.
Publicado: (2020) -
Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges
por: Bruni, Anthony, et al.
Publicado: (2014)